Atlas Trials

Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis

Clinical trial NCT04411225 · RECRUITING

Trial details

NCT number
NCT04411225
Sponsor
University of California, San Diego
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Early Psychosis
Start date
2022-06-01
Primary completion
2026-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.